The Journey Ahead…

Session Summary:

This panel shares a wide range of expertise in areas such as psychiatry, behavioural addictions, psychology, clinical informatics, digital phenotyping, computer science, language technology, neuroscience, research, policy, ethical practices, digital services provision, technology innovation, just-in-time adaptive interventions, digital access to care and equity. Each panellist will share their insights and views on what the next steps for digital mental health should include and how we can start to map the journey ahead and make decisive actions together as a community.


have your SAY:

Please submit your questions and comments that you would like to be included in this session’s Google Doc.


Panellists:


Henrietta Bowden-Jones, Director, National Problem Gambling Clinic and National Centre for Gaming Disorders

Henrietta_Bowden_Jones_2019.jpg

Henrietta M. Bowden-Jones OBE is a medical doctor, a Psychiatrist and Honorary Clinical Lecturer at Imperial College London. In 2008 she founded and became Director of the National Problem Gambling Clinic, the first and only NHS centre (CNWL NHS Trust) to treat gambling disorder. In 2018 she was part of the NHS England working group that used her clinic as a template to plan the opening of 14 more clinics across the country as part of the NHS 10 Year Long Term Plan. In 2019 with NHS funding, she opened the first NHS centre to treat Gaming Disorder following the inclusion of this addiction in the new ICD 11. She is now the Director of the newly established NHS funded National Centre for Behavioural Addictions overseeing the work of both the National Problem Gambling Clinic and the National Centre for Gaming Disorders. She is the immediate Past President of the Medical Women’s Federation (2018-2020), President Elect of the Royal Society of Medicine Psychiatry Section and the Royal College of Psychiatrists Spokesperson for Behavioral Addictions. @ArtScienceDoc


Glen Coppersmith, Founder & CEO of Qntfy

glen coppersmith.jpg

Glen Coppersmith, PhD is the Founder & CEO of Qntfy, a software company dedicated to the intersection of computer science and human behavior. Glen’s work with Qntfy has been covered in major publications including the Today Show, Mashable, The Mighty and Scientific American. He is a recognized leader in the mental health technology space, with early and frequent peer-reviewed publications on advancements made at Qntfy using digital life data to understand and improve mental health and wellbeing. Prior to founding Qntfy, Glen was the first full-time research scientist at the Human Language Technology Center of Excellence at Johns Hopkins University and held appointments at various departments within Johns Hopkins.


Tom Insel, Co-founder of NEST Health

MindStrongHeadshot.JPG

Thomas R. Insel, M.D., a psychiatrist and neuroscientist, has been a national leader in mental health research, policy, and technology.  From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH). More recently (2015 – 2017), he led the Mental Health Team at Verily (formerly Google Life Sciences) in South San Francisco, CA.  In 2017 he co-founded Mindstrong Health, a Silicon Valley start-up building tools for people with serious mental illness.  In 2020, he co-founded NEST Health, a therapeutic online community for recovery.  Since May of 2019, he has been a special advisor to California Governor Gavin Newsom and Chair of the Board of the Steinberg Institute in Sacramento, California. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.


Kate Niederhoffer, Independent Researcher

Kate-1601.jpg

Kate is a social psychologist with expertise in text analysis and digital mental health research strategy. She consults with startups and non-profits on digital mental health solutions, the development of research programs, and ethical data collection and usage practices. She was previously the Director of Research at 7 Cups, a web and mobile peer to peer emotional support platform. Prior to that, Kate was the founder of Sooth, a mobile platform for advice acquired by DreamsCloud (2016). She began her career developing social media measurement methods and standards for market research purposes at Nielsen Online (BuzzMetrics). When not in the lab, she tames the wild beasts known as her four children and seeks solace in spinning, running and yoga.


Ross O’Brien, Associate Director of Innovation and Technology at Central and North West London NHS Foundation Trust

Ross.jpg

Ross O’Brien is the Associate Director of Innovation and Technology at Central and North West London NHS Foundation Trust. He was formerly the Service Lead for the Grenfell Health and Wellbeing Service; the NHS mental health service established following the Grenfell Tower fire to support the community affected by the tragedy. Ross is a keen advocated or VR, enabling digital access to healthcare at scale and ensuring the public have a voice in the design of and access to services. Ross is also the Programme Lead of the London Digital IAPT Programme at Healthy London Partnerships and is working to establish a digital single point of access for all Londoners accessing NHS psychological therapy services. Ross is a graduate from the NHS Digital Health London Digital Pioneer Fellowship. Ross holds a Human Rights Masters from the University of London. Twitter: twitter.com/rossobr1en LinkedIn: https://www.linkedin.com/in/ross-o-brien-a270917b


Katharine Smith, Oxford Precision Psychiatry Lab, University of Oxford

thumbnail_Smith_Katharine.jpg

Dr Katharine Smith is an Honorary Consultant Psychiatrist at the University of Oxford Department of Psychiatry and NIHR (Oxford) Cognitive Health Clinical Research Facility.  She also works within the Oxford Precision Psychiatry Lab (@OxfordPPL, https://oxfordhealthbrc.nihr.ac.uk/our-work/oxppl/), an international multidisciplinary group of researchers aiming to improve current treatment practice in the NHS and across the world, using innovative approaches from AI and machine learning, to digital mental health and bioethics. She and the Oxford PPL team have been using evidence-based methods to synthesise current guidelines in mental health, to provide easy to use, open access answers for mental health clinicians to the urgent clinical questions which have emerged during the COVID-19 pandemic. These have covered a range of clinical mental health issues (including specific medications and inpatient settings) but also guidance on the practical issues for clinicians of the rapid transition to telepsychiatry required by the current crisis, applications for children and older adults and the potential for combinations with other digital technologies (https://oxfordhealthbrc.nihr.ac.uk/our-work/oxppl/table-5-digital-technologies-and-telepsychiatry/).


John Torous, Director of Digital Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School

JohnTorous.png

John Torous MD MBI is a board certified psychiatrist and clinical informaticist who investigates and creates open-source digital technologies like smartphone apps to increase access to and quality of mental health.  His work focuses on digital phenotyping, just-in-time adaptive interventions, and digital health ethics and equity. He directs the Division of Digital Psychiatry at Beth Israel Deaconess Medical Center, Harvard Medical School, where he teaches on digital mental health, runs a clinic using technology to augment care, and leads an an active research group. He also chairs the American Psychiatric Association's Health Information Technology committee and mental health app evaluation efforts. Dr. Torous is the editor of the open-access mental health technology journal JMIR Mental Health and web-editor of JAMA Psychiatry.